| SC 13D | 2024-03-12 | STONE DANIEL E. | Scinai Immunotherapeutics Ltd. | 624,000 | 13.0% | EDGAR |
| SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | Scinai Immunotherapeutics Ltd. | 518,315 | 10.0% | EDGAR |
| SC 13G/A | 2024-01-24 | STONE DANIEL E. | Scinai Immunotherapeutics Ltd. | 624,000 | 13.0% | EDGAR |
| SC 13G/A | 2024-01-02 | SABBY MANAGEMENT, LLC | Scinai Immunotherapeutics Ltd. | 220,663 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-06 | STONE DANIEL E. | BiondVax Pharmaceuticals Ltd. | 298,150 | 8.4% | EDGAR |
| SC 13G | 2023-01-04 | SABBY MANAGEMENT, LLC | BiondVax Pharmaceuticals Ltd. | 228,329 | 10.0% | EDGAR |
| SC 13D/A | 2022-12-27 | NACHT MARIUS | BiondVax Pharmaceuticals Ltd. | 170,961,770 | 12.3% | EDGAR |
| SC 13G | 2022-10-06 | STONE DANIEL E. | BiondVax Pharmaceuticals Ltd. | 37,488,520 | 5.0% | EDGAR |
| SC 13D/A | 2022-01-11 | NACHT MARIUS | BiondVax Pharmaceuticals Ltd. | 170,961,770 | 23.6% | EDGAR |
| SC 13D/A | 2021-02-09 | NACHT MARIUS | BiondVax Pharmaceuticals Ltd. | 170,961,770 | 30.6% | EDGAR |
| SC 13G/A | 2020-01-24 | Ibex Investors LLC | BiondVax Pharmaceuticals Ltd. | 14,360,000 | 3.6% | EDGAR |
| SC 13D/A | 2019-11-12 | NACHT MARIUS | BiondVax Pharmaceuticals Ltd. | 170,961,770 | 42.5% | EDGAR |
| SC 13G/A | 2019-01-28 | Ibex Investors LLC | BiondVax Pharmaceuticals Ltd. | 14,360,000 | 5.5% | EDGAR |
| SC 13G/A | 2018-02-02 | Ibex Investors LLC | BiondVax Pharmaceuticals Ltd. | 14,360,000 | 5.5% | EDGAR |
| SC 13D/A | 2017-09-27 | NACHT MARIUS | BiondVax Pharmaceuticals Ltd. | 53,760,832 | 20.6% | EDGAR |
| SC 13G | 2017-09-26 | Eastern Capital LTD | BiondVax Pharmaceuticals Ltd. | 19,000,000 | 7.3% | EDGAR |
| SC 13G | 2017-09-22 | Ibex Investors LLC | BiondVax Pharmaceuticals Ltd. | 14,342,360 | 5.5% | EDGAR |
| SC 13D | 2017-02-16 | NACHT MARIUS | BiondVax Pharmaceuticals Ltd. | 33,760,832 | 20.0% | EDGAR |
| SC 13G | 2016-02-16 | I.B.I. Investments House Ltd | BiondVax Pharmaceuticals Ltd. | - | 6.7% | EDGAR |